TY - JOUR
T1 - Viral manipulation of functionally distinct interneurons in mice, non-human primates and humans
AU - Vormstein-Schneider, Douglas
AU - Lin, Jessica D.
AU - Pelkey, Kenneth A.
AU - Chittajallu, Ramesh
AU - Guo, Baolin
AU - Arias-Garcia, Mario A.
AU - Allaway, Kathryn
AU - Sakopoulos, Sofia
AU - Schneider, Gates
AU - Stevenson, Olivia
AU - Vergara, Josselyn
AU - Sharma, Jitendra
AU - Zhang, Qiangge
AU - Franken, Tom P.
AU - Smith, Jared
AU - Ibrahim, Leena A.
AU - M astro, Kevin J.
AU - Sabri, Ehsan
AU - Huang, Shuhan
AU - Favuzzi, Emilia
AU - Burbridge, Timothy
AU - Xu, Qing
AU - Guo, Lihua
AU - Vogel, Ian
AU - Sanchez, Vanessa
AU - Saldi, Giuseppe A.
AU - Gorissen, Bram L.
AU - Yuan, Xiaoqing
AU - Zaghloul, Kareem A.
AU - Devinsky, Orrin
AU - Sabatini, Bernardo L.
AU - Batista-Brito, Renata
AU - Reynolds, John
AU - Feng, Guoping
AU - Fu, Zhanyan
AU - McBain, Chris J.
AU - Fishell, Gord
AU - Dimidschstein, Jordane
N1 - Funding Information:
We thank S. Gerard, P. Delvenne and C. Parotte for their useful comments on the manuscript. J.D. is supported by NIH grants (nos. R01-MH111529 and UG3MH120096) as well as the Simons Foundation Award (no. 566615) and a gift from the Friends-Of-FACES foundation. T.P.F. is supported by fellowships from the Belgian American Educational Foundation and the George E. Hewitt Foundation for Medical Research, an NARSAD Young Investigator grant from the Brain and Behavior Research Foundation, and a Kavli Institute for Brain and Mind Innovative research grant. C.J.M. was awarded an Intramural Research Program of NINDS and a Eunice Kennedy Shriver NICHD Intramural grant. J. Smith is supported by the NINDS (grant no. K99 NS106528). G. Fishell is supported by the NINDS (grant nos. NS081297, NS074972), NIMH (grant no. MH071679) and NIH (grant no. UG3MH120096), and the Harvard’s Dean Initiative, as well as support from the Simons Foundation award (no. 566615). We thank the individuals who selflessly volunteered to participate in this study.
Publisher Copyright:
© 2020, The Author(s), under exclusive licence to Springer Nature America, Inc.
PY - 2020/12
Y1 - 2020/12
N2 - Recent success in identifying gene-regulatory elements in the context of recombinant adeno-associated virus vectors has enabled cell-type-restricted gene expression. However, within the cerebral cortex these tools are largely limited to broad classes of neurons. To overcome this limitation, we developed a strategy that led to the identification of multiple new enhancers to target functionally distinct neuronal subtypes. By investigating the regulatory landscape of the disease gene Scn1a, we discovered enhancers selective for parvalbumin (PV) and vasoactive intestinal peptide-expressing interneurons. Demonstrating the functional utility of these elements, we show that the PV-specific enhancer allowed for the selective targeting and manipulation of these neurons across vertebrate species, including humans. Finally, we demonstrate that our selection method is generalizable and characterizes additional PV-specific enhancers with exquisite specificity within distinct brain regions. Altogether, these viral tools can be used for cell-type-specific circuit manipulation and hold considerable promise for use in therapeutic interventions.
AB - Recent success in identifying gene-regulatory elements in the context of recombinant adeno-associated virus vectors has enabled cell-type-restricted gene expression. However, within the cerebral cortex these tools are largely limited to broad classes of neurons. To overcome this limitation, we developed a strategy that led to the identification of multiple new enhancers to target functionally distinct neuronal subtypes. By investigating the regulatory landscape of the disease gene Scn1a, we discovered enhancers selective for parvalbumin (PV) and vasoactive intestinal peptide-expressing interneurons. Demonstrating the functional utility of these elements, we show that the PV-specific enhancer allowed for the selective targeting and manipulation of these neurons across vertebrate species, including humans. Finally, we demonstrate that our selection method is generalizable and characterizes additional PV-specific enhancers with exquisite specificity within distinct brain regions. Altogether, these viral tools can be used for cell-type-specific circuit manipulation and hold considerable promise for use in therapeutic interventions.
UR - http://www.scopus.com/inward/record.url?scp=85089867328&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85089867328&partnerID=8YFLogxK
U2 - 10.1038/s41593-020-0692-9
DO - 10.1038/s41593-020-0692-9
M3 - Article
C2 - 32807948
AN - SCOPUS:85089867328
SN - 1097-6256
VL - 23
SP - 1629
EP - 1636
JO - Nature Neuroscience
JF - Nature Neuroscience
IS - 12
ER -